Numerous reviews have highlighted PGRN’s key role in neurodegeneration [5, 19, 27], although other studies have not reported differences in plasma PGRN levels in AD despite a reported increase in PGRN mRNA [6, 15]. This evidence concerns the gene GRN and Alzheimer disease.